Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy

Journal of Gastrointestinal Surgery

Volumn 18, Issue 1, 2014, Pages 187-193

  Tan, Zihui ^a   Ma, Guowei ^b   Zhao, Jinming ^a   Bella, Amos Ela ^b   Rong, Tiehua ^b   Fu, Jianhua ^b   Meng, Yuqi ^b   Luo, Kongjia ^b   Situ, Dongrong ^b   Lin, Peng ^b  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Esophageal cancer; Lymph nodes; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; ESOPHAGUS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROPENSITY SCORE; RECURRENT LARYNGEAL NERVE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STOMACH; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPENSITY SCORE; RECURRENT LARYNGEAL NERVE; RETROSPECTIVE STUDIES; STOMACH; SURVIVAL RATE;

EID: 84891868071     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2411-2     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69-90.
2. Jamieson GG, Lamb PJ, Thompson SK, et al. The role of lymphadenectomy in esophageal cancer. Ann Surg, 2009; 250(2): 206-9.
3. Akiyama H, Tsurumaru, M, Udagawa, H, Kajiyama, Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994; 220(3): 364-72.
4. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg, 2004; 240(6): 962-72.
5. Nozoe T, Kakeji Y, Baba H, Maehara, Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus, 2005; 18(4): 226-9.
6. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg, 1995; 222(5): 654-62.
7. Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg, 1994; 18(2): 266-72.
8. Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus, 2001; 14(3-4): 191-6.
9. Tabira Y, Yasunaga M, Tanaka M, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg, 2000; 191(3): 232-7.
10. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
11. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33-38.
12. Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. Chicago: Springer, Inc; 2010.
13. Akiyama H, et al. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins, 1990: 19-42.
14. Bumm R, Wong J. More or less surgery for esophageal cancer: extent of lymphadenectomy for squamous cell esophageal carcinoma-How much is necessary? Dis Esophagus. 1994; 7 (3): 151-55.
15. Shiraha S. Experimental studies on the lymphatics of the esophagus from the surgical point of view. Nihon Geka Hokan, 1969; 38(4): 543-64.
16. Kuge K, Murakami G, Mizobuchi S, Hata, Y, Aikou, T, Sasaguri, S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003; 125(6): 1343-9.
17. Fujita H, Sueyoshi S, Tanaka T, Shirouzu K. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg, 2002; 8(6): 328-35.
18. Altorki NK, Zhou, X K, Stiles, B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg, 2008; 248(2): 221-6.
19. Stiles BM, Nasar Abu, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. European Journal of Cardio-Thoracic Surgery, 2012; 42 (4): 659-64.
20. Isono K, Onoda S, Okuyama, K, Sato, H. Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol, 1985; 15(1): 49-60.
21. Malassagne B, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997; 185(3): 244-9.